The equity/research analysts at the investment and securities firms listed below currently write research reports on Sinclair Pharma.
Please note that this list is subject to change and that any estimates, forecasts or opinions are made by the analysts alone and do not represent the estimates, forecasts or opinions of Sinclair Pharma or its management.
Investors may wish to contact an analyst directly in order to obtain copies of a research note. Unless otherwise indicated, the research cannot be obtained from Sinclair Pharma and there is no obligation upon the analyst to provide any report. Any reports issued may have become out of date after publication and should be read accordingly.
|Peter Welford||Jefferies||020 7029 8668|
|Jens Lindqvist||N+1 Singer||020 3205 7531|
|Max Herrmann||Stifel||020 7710 7606|
|Amy Walker||Peel Hunt||020 3597 8660|
|Nick Keher||RBC Capital Markets||0207 429 8474|